Health Catalyst (HCAT) vs Sangoma Technologies (SANG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sangoma Technologies (SANG) has outperformed Health Catalyst (HCAT) over the past year, losing 4.4% versus a loss of 38.2%. Over five years, SANG leads with a -76.0% price change compared with -96.4% for HCAT. Sangoma Technologies is the larger company by market cap ($162.2 million vs $130.9 million), about 1.2 times the size.
On valuation, Sangoma Technologies trades at a lower forward P/E (37.2x vs 232.0x for Health Catalyst).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HCAT | SANG |
|---|---|---|
| Share price | $1.74 | $4.84 |
| Market cap | $130.95M | $162.21M |
| 1-day change | -1.14% | -0.10% |
| YTD return | -26.36% | -4.44% |
| 1-year return | -38.25% | -4.44% |
| 5-year return | -96.36% | -75.97% |
| Forward P/E | 232.00 | 37.23 |
| EPS (TTM) | $-3.69 | $-2.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.62 | $5.42 |
| 52-week low | $0.955 | $3.40 |
| Distance from 52-week high | -51.87% | -10.70% |
| Analyst consensus | hold | underperform |
| Avg. price target upside | +1.72% | +7.44% |
| Average volume | 626.93K | 125.91K |
| Shares outstanding | 75.26M | 33.50M |
| Employees | 1,200 | 569 |
| Sector | Technology | Technology |
| Industry | Computer Software: Programming Data Processing | Computer Software: Programming Data Processing |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SANG has outperformed HCAT by 33.8 percentage points over the past year.
About Health Catalyst
HCAT stock →Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.
Technology · Computer Software: Programming Data Processing · 1,200 employees
About Sangoma Technologies
SANG stock →Sangoma Technologies Corporation, together with its subsidiaries, develops, manufactures, distributes, and supports voice and data connectivity components for software-based communication applications in the United States of America and internationally. The company offers communications platforms comprising pure cloud and hybrid unified communications as a service, and on-premises systems; retail and wholesale SIP trunking, as well as fax as a service; Sangoma TeamHub, a unified communications and collaboration platform for business productivity; Sangoma Meet, a multi-party video conferencing platform; and Sangoma CX, a cloud-native contact center suite that enables businesses to manage inbound interactions across multiple channels.
Technology · Computer Software: Programming Data Processing · 569 employees
HCAT vs SANG FAQ
Which is bigger, Health Catalyst or Sangoma Technologies?
Sangoma Technologies (SANG) is larger, with a market capitalization of $162.21M compared with $130.95M for Health Catalyst (HCAT).
Which stock has performed better over the past year, HCAT or SANG?
SANG returned -4.44% over the past 12 months, compared with -38.25% for HCAT (price return, excluding dividends). Past performance does not predict future results.
Are Health Catalyst and Sangoma Technologies in the same industry?
Yes. Both are classified in the Computer Software: Programming Data Processing industry within the Technology sector.